Cargando…
Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
Pompe disease, also known as glycogen storage disease type II, is caused by the lack or deficiency of a single enzyme, lysosomal acid alpha-glucosidase, leading to severe cardiac and skeletal muscle myopathy due to progressive accumulation of glycogen. The discovery that acid alpha-glucosidase resid...
Autores principales: | Meena, Naresh K., Raben, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564159/ https://www.ncbi.nlm.nih.gov/pubmed/32962155 http://dx.doi.org/10.3390/biom10091339 |
Ejemplares similares
-
Pompe disease: Shared and unshared features of lysosomal storage disorders
por: Lim, Jeong-A, et al.
Publicado: (2015) -
Autophagy in lysosomal storage disorders
por: Lieberman, Andrew P., et al.
Publicado: (2012) -
Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease
por: Meena, Naresh Kumar, et al.
Publicado: (2020) -
Impaired autophagy: The collateral damage of lysosomal storage disorders
por: Myerowitz, Rachel, et al.
Publicado: (2020) -
AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice
por: Meena, Naresh K., et al.
Publicado: (2023)